DIH Appoints Professor Nick Ward, M.D., to DIH Scientific Advisory Board
DIH (NASDAQ:DHAI), a global provider of advanced robotic rehabilitation devices, has appointed Professor Nick Ward, M.D. to its Scientific Advisory Board. Professor Ward, a distinguished expert in upper limb neurorehabilitation, serves as Professor of Clinical Neurology and Neurorehabilitation at University College London and the National Hospital for Neurology and Neurosurgery.
The DIH Scientific Advisory Board, now comprising nine members, advises the company on technical and scientific matters, clinical trends, product development, and research initiatives. Professor Ward brings expertise from leading a pioneering high-intensity Upper Limb Neurorehabilitation programme and researching neurobiological mechanisms in arm and hand function recovery.
DIH (NASDAQ:DHAI), fornitore globale di dispositivi avanzati per la riabilitazione robotica, ha nominato il Professor Nick Ward, M.D. nel suo Comitato Scientifico. Il Professor Ward, esperto rinomato nella neuroriabilitazione degli arti superiori, 猫 Professore di Neurologia Clinica e Neuroriabilitazione presso l'University College London e il National Hospital for Neurology and Neurosurgery.
Il Comitato Scientifico di DIH, che ora conta nove membri, fornisce consulenza all'azienda su questioni tecniche e scientifiche, tendenze cliniche, sviluppo prodotto e iniziative di ricerca. Il Professor Ward apporta la sua esperienza guidando un programma innovativo di neuroriabilitazione ad alta intensit脿 per gli arti superiori e studiando i meccanismi neurobiologici nel recupero della funzione di braccio e mano.
DIH (NASDAQ:DHAI), proveedor global de dispositivos avanzados de rehabilitaci贸n rob贸tica, ha nombrado a el Profesor Nick Ward, M.D. en su Consejo Asesor Cient铆fico. El Profesor Ward, experto destacado en neurorehabilitaci贸n de extremidades superiores, es Profesor de Neurolog铆a Cl铆nica y Neurorehabilitaci贸n en University College London y en el National Hospital for Neurology and Neurosurgery.
El Consejo Asesor Cient铆fico de DIH, que ahora cuenta con nueve miembros, asesora a la empresa en asuntos t茅cnicos y cient铆ficos, tendencias cl铆nicas, desarrollo de productos e iniciativas de investigaci贸n. El Profesor Ward aporta su experiencia liderando un programa pionero de neurorehabilitaci贸n de extremidades superiores de alta intensidad e investigando los mecanismos neurobiol贸gicos en la recuperaci贸n de la funci贸n del brazo y la mano.
DIH (NASDAQ:DHAI)電� 觳嫧 搿滊磭 鞛櫆 旮瓣赴毳� 鞝滉车頃橂姅 旮�搿滊矊 旮办梾鞙茧, 雼� 鞗岆摐 甑愳垬, M.D.毳� 瓿柬暀 鞛愲 鞙勳洂須岇棎 鞛勲獏頄堨姷雼堧嫟. 鞗岆摐 甑愳垬電� 靸侅 鞁犼步鞛櫆 攵勳暭鞚� 鞝�氇呿暅 鞝勲臧�搿�, 霟半崢 雽�頃欔祼 雽�頃欖洂 氚� 鞁犼步頃� 氚� 鞁犼步鞕戈臣 甑氤戩洂鞐愳劀 鞛勳儊 鞁犼步頃� 氚� 鞁犼步鞛櫆 甑愳垬搿� 鞛 欷戩瀰雼堧嫟.
顺勋灛 9氇�鞙茧 甑劚霅� DIH 瓿柬暀 鞛愲 鞙勳洂須岆姅 旮办垹 氚� 瓿柬暀鞝� 靷晥, 鞛勳儊 霃欗枼, 鞝滍拡 臧滊皽, 鞐瓣惮 鞚措媹靺旐嫲敫岇棎 雽�頃� 須岇偓鞐� 鞛愲鞚� 鞝滉车頃╇媹雼�. 鞗岆摐 甑愳垬電� 瓿犼皶霃� 靸侅 鞁犼步鞛櫆 頂勲攴鸽灗鞚� 靹犽弰頃橂┌ 韺旉臣 靻� 旮半姤 須岆车鞚� 鞁犼步靸濍頃欖爜 氅旍护雼堨 鞐瓣惮 瓴巾棙鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
DIH (NASDAQ:DHAI), fournisseur mondial de dispositifs avanc茅s de r茅茅ducation robotique, a nomm茅 le Professeur Nick Ward, M.D. au sein de son Conseil Consultatif Scientifique. Le Professeur Ward, expert reconnu en neuro-r茅茅ducation des membres sup茅rieurs, est Professeur de Neurologie Clinique et de Neuro-r茅茅ducation 脿 l'University College London et au National Hospital for Neurology and Neurosurgery.
Le Conseil Consultatif Scientifique de DIH, qui compte d茅sormais neuf membres, conseille l'entreprise sur les questions techniques et scientifiques, les tendances cliniques, le d茅veloppement des produits et les initiatives de recherche. Le Professeur Ward apporte son expertise issue de la direction d'un programme novateur de neuro-r茅茅ducation intensive des membres sup茅rieurs et de la recherche sur les m茅canismes neurobiologiques impliqu茅s dans la r茅cup茅ration des fonctions du bras et de la main.
DIH (NASDAQ:DHAI), ein weltweit f眉hrender Anbieter fortschrittlicher robotischer Rehabilitationsger盲te, hat Professor Nick Ward, M.D. in seinen Wissenschaftlichen Beirat berufen. Professor Ward, ein ausgewiesener Experte f眉r Neurorehabilitation der oberen Extremit盲ten, ist Professor f眉r Klinische Neurologie und Neurorehabilitation am University College London sowie am National Hospital for Neurology and Neurosurgery.
Der Wissenschaftliche Beirat von DIH, der nun aus neun Mitgliedern besteht, ber盲t das Unternehmen in technischen und wissenschaftlichen Fragen, klinischen Trends, Produktentwicklung und Forschungsinitiativen. Professor Ward bringt seine Expertise aus der Leitung eines wegweisenden hochintensiven Neurorehabilitationsprogramms f眉r die oberen Extremit盲ten sowie der Erforschung neurobiologischer Mechanismen bei der Wiederherstellung der Arm- und Handfunktion ein.
- None.
- None.
NORWELL, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (鈥淒IH鈥�)(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Professor Nick Ward, M.D. to its Scientific Advisory Board.
Nick Ward, M.D., is a Professor of Clinical Neurology and Neurorehabilitation at the Institute of Neurology at University College London and at the National Hospital for Neurology and Neurosurgery in London, UK. He is a distinguished clinical expert in upper limb neurorehabilitation, leading a first-of-its-kind dedicated high-intensity Upper Limb Neurorehabilitation programme, and investigates neurobiological mechanisms involved in the recovery of arm and hand functions.
The DIH Scientific Advisory Board (DIH SAB) is composed of leading scientists and clinicians with expertise across a range of technical and clinical disciplines relevant to DIH鈥檚 advanced rehabilitation solutions, the clinical environments where these solutions are applied, and the geographical regions where DIH products are sold. The SAB advises DIH on technical and scientific pursuits, offers insights into the latest trends in clinical and scientific communities, provides feedback on product development, and advises DIH on research plans and projects.
Dr. Bettina Studer Pastore, Global Head of Scientific and Clinical Affairs at DIH, stated: 鈥淲e are honored to welcome Professor Nick Ward to the DIH Scientific Advisory Board. Nick鈥檚 exceptional clinical expertise in upper limb rehabilitation, his pioneering research and his unwavering commitment to high-intensity training and evidence-based rehabilitation make him an invaluable addition. As DIH continues to transform the standard of care in rehabilitation through advanced technologies, Nick鈥檚 guidance will play a pivotal in shaping our innovation and impact.鈥�
Professor Ward commented on the appointment: 鈥淚鈥檓 delighted to be joining the DIH Scientific Advisory Board at this exciting time in neurorehabilitation. I hope to be able to bring some clinical experience to bear on the future of new approaches to support motor recovery after stroke.鈥�
With the appointment of Professor Ward, the DIH Scientific Advisory Board now comprises nine distinguished members, further strengthening the company鈥檚 commitment to evidence-based innovation and clinical excellence in neurorehabilitation.
About DIH Holding US, Inc.
DIH stands for the vision to 鈥淒eliver Inspiration & Health鈥� to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.
Caution Regarding Forward-Looking Statements
This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH鈥檚 projected future results. These forward-looking statements generally are identified by the words 鈥渂elieve,鈥� 鈥減roject,鈥� 鈥渆xpect,鈥� 鈥渁nticipate,鈥� 鈥渆stimate,鈥� 鈥渋ntend,鈥� 鈥渟trategy,鈥� 鈥渇uture,鈥� 鈥渙pportunity,鈥� 鈥減lan,鈥� 鈥渕ay,鈥� 鈥渟hould,鈥� 鈥渨ill,鈥� 鈥渨ould,鈥� 鈥渨ill be,鈥� 鈥渨ill continue,鈥� 鈥渨ill likely result,鈥� and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the ability of DIH to achieve its projected revenue, the failure of DIH realize the anticipated benefits of the recently-completed business combination and access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.
Investor Contact
Greg Chodaczek
[email protected]
FAQ
Who is Professor Nick Ward and why did DIH (NASDAQ:DHAI) appoint him to their Scientific Advisory Board?
What is the role of DIH's Scientific Advisory Board?
How many members are now on DIH's Scientific Advisory Board?
What does DIH (NASDAQ:DHAI) specialize in?
What is Professor Nick Ward's background and expertise?
